A 2nd case series on IL-6 inhibition in COVID-ARDS.

- n=21
- no control group
- ~1/3 got better
- ~1/3 got worse
- ~1/3 was the same (still in ARDS)
- CRP improved (read: they got the drug)

Can't make any better clinical decisions based on this.
You can follow @MaxKonigMD.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: